Development of a novel hybrid alphavirus-SARS-CoV-2 particle for rapid in vitro screening and quantification of neutralization antibodies, viral variants, and antiviral drugs

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Immunology

Microbiology

Biology

Immunology

Microbiology

Virology

Infectivity

Show all topics

DOI

10.1101/2020.12.22.423965

License

CC-BY-NC-ND

Other Formats

PDF